Treatment of pediatric relapsed and refractory acute myeloid leukemia
Background. Despite the modern therapy programs including hematopoietic stem cell transplantation, the treatment outcomes for children with acute myeloid leukemia (AML) remain unsatisfactory. The 5‑year overall survival rate is about 70 %. The 5‑year overall survival rate for patients with relapsed...
Saved in:
Main Authors: | F. A. Makhacheva, T. T. Valiev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2023-05-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric acute myeloid leukemias treatment: current scientific view
by: F. A. Makhacheva, et al.
Published: (2020-04-01) -
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01) -
Clinical features of secondary acute myeloid leukemia in children
by: F. A. Makhacheva, et al.
Published: (2020-12-01) -
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01) -
CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01)